Medications

New tuberculosis drug regimen slashes treatment time

Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment timeā€”and ...

Diseases, Conditions, Syndromes

Boosting host immune defenses to treat tuberculosis

Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard for people to sustain. Moreover, the bacteria often develop drug resistance, and many people ...

Diseases, Conditions, Syndromes

Drug-resistant tuberculosis: A new study offers new hope

Tuberculosis (TB) is the leading cause of death in the world from a single infectious disease, causing more deaths than HIV/AIDS. In 2017, 10 million people developed TB disease globally and an estimated 1.6 million died.

Diseases, Conditions, Syndromes

Aspirin to fight an expensive global killer infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood ...

page 1 from 11